Alta Advisers LTD Vertex Pharmaceuticals Inc Transaction History
Alta Advisers LTD
- $230 Million
- Q1 2025
A detailed history of Alta Advisers LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alta Advisers LTD holds 1,271 shares of VRTX stock, worth $647,574. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,271
Previous 871
45.92%
Holding current value
$647,574
Previous $350,000
76.0%
% of portfolio
0.27%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,804Shares Held
223MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...